BLT 0.00% 2.6¢ benitec biopharma limited

in-vivo non-viral delivery of shrna for mi, page-3

  1. 2,027 Posts.
    Geez, sometimes you just gotta get excited, I mean here we have something that makes Mesoblasts technology potentially obsolete, ddRNAi can do the recruitment of the body's own intrinsic stem cells. Also this new technique seems to circumvent every single objection to using viral vectors. And our share price...what the?!?!
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.